Thoratec heart pump linked with blood clots


Thoratec's (THOR) HeartMate II heart pump has been linked with the formation of potentially fatal blood clots in patients, a study in the New England Journal of Medicine has found.

Seventy two clots occurred in 66 patients at three institutions where 895 devices were inserted from 2004-2013.

However, doctors aren't necessarily going to stop using HeartMate II. "I don't think anybody that's in this field is ready to say 'Gee, we have to stop using these,'" says cardiologist Randall Starling. "The alternative isn't good. But we have to better understand their limitations and how to manage them."

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs